Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01400334 · ClinicalTrials.gov registry record
Prediction of ARrhythmic Events With Positron Emission Tomography
A clinical trial of Ischemic Cardiomyopathy and Hibernating Myocardium, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- 257
- Enrollment target
- 1
- Study location
NCT01400334 is a study of Ischemic Cardiomyopathy and Hibernating Myocardium that has completed, run by State University of New York at Buffalo. The registered enrollment target is 257 participants, below the 353-participant average among 10 other Ischemic Cardiomyopathy trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01400334, a study of Ischemic Cardiomyopathy and Hibernating Myocardium, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- 257 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypothesis of PAREPET is that hibernating myocardium (viable myocardium with reduced resting flow) and/or viable but denervated myocardium can predict the risk of sudden death in subjects with ischemic cardiomyopathy.
Conditions Studied
Interventions
- RADIATION Positron Emission Tomography
Study Locations (1)
New York
- SUNYBuffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2004-07 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01400334
The ClinicalTrials.gov registry entry for NCT01400334 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 353-participant average among 10 other Ischemic Cardiomyopathy trials with a reported enrollment target (27% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Ischemic Cardiomyopathy appearing as the primary indexed condition, and to 1 intervention - of which Positron Emission Tomography is the first listed.
NCT01400334 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01400334 about?
NCT01400334 is a clinical study titled "Prediction of ARrhythmic Events With Positron Emission Tomography". The hypothesis of PAREPET is that hibernating myocardium (viable myocardium with reduced resting flow) and/or viable but denervated myocardium can predict the risk of sudden death in subjects with ischemic cardiomyopathy.
What is the current status of trial NCT01400334?
This trial is currently completed. The enrollment target is 257 participants. The study started on 2004-07. Estimated completion is 2012-12.
What conditions does trial NCT01400334 study?
This clinical trial studies the following conditions: Ischemic Cardiomyopathy, Hibernating Myocardium, Nerve; Disorder, Sympathetic.
What interventions are being tested in trial NCT01400334?
The interventions under investigation include: Positron Emission Tomography (RADIATION).
Who is sponsoring clinical trial NCT01400334?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01400334 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Left Ventricular Structural Predictors of Sudden Cardiac Death
RECRUITING
-
Implantable Cardioverter Defibrillator (ICD Registry)
RECRUITING
-
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
RECRUITING · NA
-
Phenotypic Classification of FMR With CMR
RECRUITING
-
Venous Ethanol for Ventricular Tachycardia
RECRUITING · Phase 2
-
Impella Supported OPCABG
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.